Cell and Gene Therapy CMO and CDMO Facilities

Searchable and sortable database of 188 Cell and Gene Therapy CMOs / CDMOs worldwide as of 12 Sept. 2020, including 140 companies and 48 academic or government facilities.

This is a global database of facilities that provide (mostly or exclusively) services as contract manufacturing organizations (CMO) and/or contract development and manufacturing organizations (CDMO) for the cell and gene therapy industry worldwide.

Included: Manufacturers of therapeutic cell products (unmodified or gene-modified), iPS cell lines for therapeutic products, viral vectors and DNA plasmids for cell and gene therapy industry.

Excluded: Contract research organizations (CROs) not performing manufacture of the therapeutic product, vendors of supplies (reagents, devices, etc.) 

For each company:

• Facility name
• Link to facility website if available
• Country of origin
• CMO/CDMO service expertise
• Mergers & Acquisitions, Notes
• The excel file has separate lists for CMO/CDMO that are Industry versus Academic/ Government facilities.

Our last release in March 2020 held 174 companies. Since then, we have added 16 organizations (14 industry companies and 2 academic/government) and removed 2 organizations due to acquisitions.

Geographically, our January 2020 database held 69 facilities operating in North America (40%), 69 in Europe (40%), and 35 (20%) in Asia. We had 173 locations for the 161 facilities in our Jan. 2020 database because some of the companies have laboratories in more than one country.

Attachment	Size
SAMPLE Cell and Gene Therapy CMO and CDMO Facilities	11.3 KB